Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vericel CorpVCEL · Entity 4481 | Chief Legal Officer | June 26, 2026 | June 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vericel Corp
Report date June 26, 2026 · Filed June 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,647 |
Last balance in matching sequence
After 2026-06-26 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-06-26 · Exercise / conversion · Acquired 15,000 · Balance 16,647 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 2 · 2026-06-26 · Sale · Disposed 15,000 · Balance 1,647 F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025. F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.25 · Expires 2029-11-04 | Direct | 55,000 |
Reported balance
After 2026-06-26 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-26 · Exercise / conversion · Acquired 15,000 · Balance 55,000 F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
F3: These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2021 Filed Feb 22, 2021 21:10 UTC | Vericel Corp VCEL · Entity 4481 | GrantRestricted Stock Unit · Derivative | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-21-000544 · primary_01.xml · derivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 19, 2022. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 21:10 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 3,890 | $0.00 Strike: $51.40 | $0.00 |
DisclosureSEC source: 0001593968-21-000544 · primary_01.xml · derivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,890 Underlying: Common Stock · 3,890 shares Expires 2031-02-19 F1 · derivative.exercise_date: These options shall begin vesting on February 19, 2021 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| September 30, 2020 Filed Jan 28, 2021 21:19 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 138 | $12.64 | $1,744.25 |
DisclosureSEC source: 0001593968-21-000237 · primary_01.xml · nonDerivative · entry 3 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,989 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2020 Filed Jan 28, 2021 21:19 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 1,042 | $7.23 | $7,537.31 |
DisclosureSEC source: 0001593968-21-000237 · primary_01.xml · nonDerivative · entry 2 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,851 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 31, 2020 Filed Jan 28, 2021 21:19 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 809 | $7.79 | $6,305.75 |
DisclosureSEC source: 0001593968-21-000237 · primary_01.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.